Amy Q. Wang

2.6k total citations
31 papers, 1.1k citations indexed

About

Amy Q. Wang is a scholar working on Molecular Biology, Infectious Diseases and Oncology. According to data from OpenAlex, Amy Q. Wang has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Infectious Diseases and 8 papers in Oncology. Recurrent topics in Amy Q. Wang's work include HIV/AIDS drug development and treatment (6 papers), Hepatitis C virus research (5 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Amy Q. Wang is often cited by papers focused on HIV/AIDS drug development and treatment (6 papers), Hepatitis C virus research (5 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Amy Q. Wang collaborates with scholars based in United States, United Kingdom and Czechia. Amy Q. Wang's co-authors include Xin Xu, Gary Herman, Li Chen, Wei Zeng, John A. Wagner, Arthur Bergman, Karen Snyder, Michael Tanen, Wesley Tanaka and Deborah Hilliard and has published in prestigious journals such as Applied and Environmental Microbiology, The Journal of Clinical Endocrinology & Metabolism and Cancer Research.

In The Last Decade

Amy Q. Wang

29 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amy Q. Wang United States	17	390	328	225	149	148	31	1.1k
Anlin Peng China	19	431 1.1×	159 0.5×	117 0.5×	140 0.9×	71 0.5×	30	1.2k
Gwendolyn A. Marriner United States	9	352 0.9×	153 0.5×	110 0.5×	57 0.4×	171 1.2×	11	1.1k
Gang Luo China	17	468 1.2×	113 0.3×	176 0.8×	71 0.5×	63 0.4×	60	1.3k
Mariko Nakano Japan	19	620 1.6×	140 0.4×	91 0.4×	81 0.5×	55 0.4×	63	1.4k
Hiroko Murakami Japan	21	1.2k 3.0×	117 0.4×	272 1.2×	113 0.8×	89 0.6×	57	2.0k
Michael Christensen Denmark	19	479 1.2×	144 0.4×	84 0.4×	47 0.3×	93 0.6×	47	1.3k
Russell Gotschall United States	21	533 1.4×	118 0.4×	178 0.8×	112 0.8×	133 0.9×	37	1.7k
Hitoshi Ishizuka Japan	17	468 1.2×	150 0.5×	500 2.2×	80 0.5×	166 1.1×	56	1.4k
Heather Eng United States	17	427 1.1×	76 0.2×	176 0.8×	99 0.7×	29 0.2×	41	865

Countries citing papers authored by Amy Q. Wang

Since Specialization

Citations

This map shows the geographic impact of Amy Q. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Q. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Q. Wang more than expected).

Fields of papers citing papers by Amy Q. Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Q. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Q. Wang. The network helps show where Amy Q. Wang may publish in the future.

Co-authorship network of co-authors of Amy Q. Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Q. Wang. A scholar is included among the top collaborators of Amy Q. Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Q. Wang. Amy Q. Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lin, Yi‐Han, Aleksandra Głogowska, Thatchawan Thanasupawat, et al.. (2025). The Brain-Penetrant Pan-ErbB Inhibitor Poziotinib Effectively Targets HER2+ Breast Cancer Brain Metastases. Cancer Research. 85(8). 1514–1529. 1 indexed citations

Mandecki, Włodek, Wenjuan Ye, Amy Q. Wang, et al.. (2024). Identification of an antibiotic from an HTS targeting EF-Tu:tRNA interaction: a prospective topical treatment for MRSA skin infections. Applied and Environmental Microbiology. 91(1). e0204624–e0204624.

Sarkar, Rhitajit, Abhijeet Kapoor, Elena Eliseeva, et al.. (2024). An Orally Efficacious Thyrotropin Receptor Ligand Inhibits Growth and Metastatic Activity of Thyroid Cancers. The Journal of Clinical Endocrinology & Metabolism. 109(9). 2306–2316. 5 indexed citations

Padilha, Elias Carvalho, Mengbi Yang, Pranav Shah, et al.. (2023). In vitro and in vivo pharmacokinetic characterization, chiral conversion and PBPK scaling towards human PK simulation of S-MRI-1867, a drug candidate for Hermansky-Pudlak syndrome pulmonary fibrosis. Biomedicine & Pharmacotherapy. 168. 115178–115178. 3 indexed citations

Yang, Mengbi, Amy Q. Wang, Elias Carvalho Padilha, et al.. (2023). Use of physiological based pharmacokinetic modeling for cross-species prediction of pharmacokinetic and tissue distribution profiles of a novel niclosamide prodrug. Frontiers in Pharmacology. 14. 1099425–1099425. 9 indexed citations

Williams, J. W., Vishal B. Siramshetty, Ðắc-Trung Nguyễn, et al.. (2022). Using in vitro ADME data for lead compound selection: An emphasis on PAMPA pH 5 permeability and oral bioavailability. Bioorganic & Medicinal Chemistry. 56. 116588–116588. 32 indexed citations

Wang, Amy Q., Elias Carvalho Padilha, Mengbi Yang, et al.. (2022). Preclinical Pharmacokinetics and In Vitro Properties of GS-441524, a Potential Oral Drug Candidate for COVID-19 Treatment. Frontiers in Pharmacology. 13. 918083–918083. 16 indexed citations

Padilha, Elias Carvalho, Pranav Shah, Amy Q. Wang, et al.. (2020). Metabolism and pharmacokinetics characterization of metarrestin in multiple species. Cancer Chemotherapy and Pharmacology. 85(4). 805–816. 9 indexed citations

Xu, Xin, Michael Zhang, Yifan Shi, et al.. (2019). Quantitation of cytidine‐5′‐monophospho‐N‐acetylneuraminic acid in human leukocytes using LC–MS/MS: method development and validation. Biomedical Chromatography. 34(2). e4735–e4735. 5 indexed citations

10.

Yang, Shyh‐Ming, Daniel J. Urban, Makoto Yoshioka, et al.. (2018). Discovery and lead identification of quinazoline-based BRD4 inhibitors. Bioorganic & Medicinal Chemistry Letters. 28(21). 3483–3488. 13 indexed citations

11.

Yang, Shyh‐Ming, Natalia J. Martinez, Adam Yasgar, et al.. (2018). Discovery of Orally Bioavailable, Quinoline-Based Aldehyde Dehydrogenase 1A1 (ALDH1A1) Inhibitors with Potent Cellular Activity. Journal of Medicinal Chemistry. 61(11). 4883–4903. 70 indexed citations

12.

Jiang, Jian‐kang, Xiuli Huang, Khalida Shamim, et al.. (2018). Discovery of 3-(4-sulfamoylnaphthyl)pyrazolo[1,5-a]pyrimidines as potent and selective ALK2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 28(20). 3356–3362. 19 indexed citations

13.

Xu, Xin, Amy Q. Wang, Lea Latham, et al.. (2017). Safety, pharmacokinetics and sialic acid production after oral administration of N -acetylmannosamine (ManNAc) to subjects with GNE myopathy. Molecular Genetics and Metabolism. 122(1-2). 126–134. 44 indexed citations

14.

Wang, Amy Q., Emma Hughes, Wenwei Huang, Edward H. Kerns, & Xin Xu. (2017). Quantification of cyclocreatine in mouse and rat plasma using hydrophilic-interaction ultra-performance liquid chromatography-tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 145. 629–633. 4 indexed citations

15.

Mukhopadhyay, Rupkatha, Sujayita Roy, Rajkumar Venkatadri, et al.. (2016). Efficacy and Mechanism of Action of Low Dose Emetine against Human Cytomegalovirus. PLoS Pathogens. 12(6). e1005717–e1005717. 46 indexed citations

16.

He, Shanshan, Jingbo Xiao, Andrés E. Dulcey, et al.. (2015). Discovery, Optimization, and Characterization of Novel Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection. Journal of Medicinal Chemistry. 59(3). 841–853. 31 indexed citations

17.

Herman, Gary, Goutam C. Mistry, Bingming Yi, et al.. (2010). Evaluation of pharmacokinetic parameters and dipeptidyl peptidase‐4 inhibition following single doses of sitagliptin in healthy, young Japanese males. British Journal of Clinical Pharmacology. 71(3). 429–436. 29 indexed citations

18.

Herman, Gary, Arthur Bergman, Fang Liu, et al.. (2006). Pharmacokinetics and Pharmacodynamic Effects of the Oral DPP‐4 Inhibitor Sitagliptin in Middle‐Aged Obese Subjects. The Journal of Clinical Pharmacology. 46(8). 876–886. 146 indexed citations

19.

Bergman, Arthur, Yanyan Zhou, Bingming Yi, et al.. (2006). Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: A double-blind, randomized, placebo-controlled study in healthy male volunteers. Clinical Therapeutics. 28(1). 55–72. 220 indexed citations

20.

Wang, Amy Q., Wei Zeng, Donald G. Musson, John Rogers, & Alison L. Fisher. (2002). A rapid and sensitive liquid chromatography/negative ion tandem mass spectrometry method for the determination of an indolocarbazole in human plasma using internal standard (IS) 96‐well diatomaceous earth plates for solid‐liquid extraction. Rapid Communications in Mass Spectrometry. 16(10). 975–981. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact